Corrigendum to “Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes” [Europ. J. Paediatr. Neurol. 41 (2022) 8–18 doi.org/10.1016/j.ejpn.2022.08.006, (S1090379822001246), (10.1016/j.ejpn.2022.08.006)]

Yılmaz, ÜnsalGücüyener, KıvılcımYavuz, Merve˙ Ibrahim OncelCanpolat, MehmetSaltık, SemaÜnver, Olcay2025-03-202025-03-2020241090-3798https://doi.org/10.1016/j.ejpn.2024.11.006https://hdl.handle.net/20.500.14034/2069The authors would like to apologise for any inconvenience caused. © 2024 European Paediatric Neurology Societyeninfo:eu-repo/semantics/closedAccessadultadverse drug reactioncontrolled studyerratumhumanCorrigendum to “Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes” [Europ. J. Paediatr. Neurol. 41 (2022) 8–18 doi.org/10.1016/j.ejpn.2022.08.006, (S1090379822001246), (10.1016/j.ejpn.2022.08.006)]Erratum10.1016/j.ejpn.2024.11.0062-s2.0-85210942515Q1